Aichi Tokei Denki (7723) FY2027 Q1 Earnings Report

Quick View

Executive Summary

Despite a +10.1% year-on-year increase in revenue, the combination of a decline in gross margin and a sharp increase in SG&A expenses caused the Company’s operating result to shift from a profit to a loss. Revenue was ¥13.78B (¥12.52B in the previous year, YoY +10.1%), operating income was ¥-0.74B (¥0.84B in the previous year, YoY -187.8%), ordinary income was ¥-0.58B (¥1.07B in the previous year, YoY -154.4%), and net income was ¥-0.40B (¥0.77B in the previous year, YoY -152.2%). The benefit of higher revenue was offset by deterioration in the gross margin due to an increase in the cost ratio (23.5% in the previous year → 20.8%) and a sharp rise in the SG&A ratio (16.8% in the previous year → 26.1%), ultimately resulting in a net loss. This is the key feature of the current earnings results.

Factors Behind Changes in Business Performance

【Revenue】Revenue was ¥13.78B, representing a year-on-year increase of +10.1%. As the Company has a high weighting toward measurement-equipment-related operations and a strong degree of concentration in a single business, disclosure of segment information has been omitted. No disclosure data is available regarding the regional composition of revenue.

【Profit and Loss】Gross profit was ¥2.86B, with a gross margin of 20.8%, down approximately 2.7pt from 23.5% in the previous year, confirming an increase in the cost ratio. SG&A expenses increased 71.3% to ¥3.60B from ¥2.10B in the previous year, while the SG&A ratio rose approximately 9.3pt to 26.1% from 16.8%. Consequently, the operating result shifted from the previous year’s operating profit of ¥0.84B to an operating loss of ¥0.74B. Even after factoring in non-operating income of ¥0.16B (including dividend income of ¥0.12B), ordinary income remained at ¥-0.58B, while the net loss narrowed to ¥-0.40B due to the recognition of deferred tax benefits. Although revenue increased, deterioration in the cost structure led to lower profit and ultimately a shift into the red; the results can therefore be characterized as higher revenue but lower profit (shift into the red).

Segment Analysis

The Group has a high weighting toward measurement-equipment-related operations and has omitted disclosure of segment-level revenue and profit/loss information because the materiality of such disclosure is limited.

Key Financial Indicators

【Profitability】The operating margin was -5.3%, deteriorating by approximately 12.0pt from +6.7% in the previous year, while the net profit margin also declined to -2.9% from +6.2% in the previous year. ROE was -0.8%, mainly due to the shift of net income into the red. 【Cash Quality】Cash and deposits were ¥9.05B, broadly flat compared with ¥9.17B in the previous year, while accounts receivable decreased 25.6% to ¥9.23B from ¥12.41B in the previous year. In contrast, work in process increased 4.4% to ¥12.62B from ¥12.08B in the previous year, accounting for 81.4% of total inventories (¥15.50B). 【Investment Efficiency】Total asset turnover relative to revenue remained moderate, while total assets contracted to ¥66.53B from ¥70.28B in the previous year. 【Financial Soundness】The equity ratio rose to 76.6% from 74.8% in the previous year. Interest-bearing debt was limited at ¥0.70B, and the Company was effectively in a net cash position relative to cash and deposits of ¥9.05B.

Cash Flow Analysis

As no numerical data from the statement of cash flows has been disclosed, funding trends are analyzed based on changes in the balance sheet. While cash and deposits remained broadly flat at ¥9.05B compared with ¥9.17B in the previous year, the recognition of an operating loss and increases in inventories of work in process (¥12.62B, up +4.4% year on year) and finished goods (¥2.54B, up +8.0% year on year) may have tied up funds in working capital. Accounts receivable decreased 25.6% to ¥9.23B from ¥12.41B in the previous year, indicating an improvement in cash collection; however, accounts payable also decreased 19.6% to ¥3.72B from ¥4.63B in the previous year, indicating that cash outflows on the payment side also progressed. The provision for product warranties increased substantially to ¥2.42B from ¥1.13B in the previous year, warranting attention as a potential future cash outflow burden. Interest-bearing debt was limited at ¥0.70B, indicating a low degree of reliance on external financing.

Quality of Earnings

The Company’s recurring earnings are predominantly derived from operating profit/loss based on product sales. Non-operating income was limited to ¥0.16B (including dividend income of ¥0.12B), while non-operating expenses were ¥0.01B, resulting in limited distortion of earnings from non-operating items. Against an ordinary loss of ¥0.58B, the net loss was limited to ¥0.40B. This divergence was primarily attributable to a reduction in the tax burden from deferred taxes (-¥0.206B), with a temporary tax effect compressing the final net loss. Comprehensive income was ¥-0.56B, below net income of ¥-0.40B. Unrealized valuation differences on securities of ¥-0.19B and adjustments related to retirement benefits of ¥-0.06B made negative contributions, while foreign currency translation adjustments were a positive factor of ¥0.09B. The sharp increase in the provision for product warranties (¥1.13B in the previous year → ¥2.42B) represents the advance recognition of future expenses, while also indicating an increase in quality-related costs. This point warrants attention when assessing the quality of operating earnings.

Earnings Forecast and Guidance

The full-year Company forecast calls for revenue of ¥60.48B (YoY +2.3%), operating income of ¥3.73B (YoY -20.8%), and ordinary income of ¥4.07B (YoY -21.9%). Against these forecasts, Q1 revenue progress was 22.8%, slightly below the evenly distributed progress benchmark of 25%, while operating income and ordinary income were both negative, resulting in negative progress rates and a substantial shortfall. The earnings forecast was revised during the current quarter, reflecting a review of the assumptions underlying the full-year plan. There was no revision to the dividend forecast, which remains at ¥120 per year. Revenue progress assumes achievement of a plan weighted toward the second half, while recovery in profitability will require normalization of inventory and quality-related costs.

Shareholder Returns

The full-year dividend forecast is ¥120, representing a planned increase from the previous year’s actual dividend of ¥45. There was no revision to the dividend forecast during the current quarter. The payout ratio based on the Company’s forecast EPS of ¥232.7 is 51.6% (¥120 ÷ ¥232.7). Although the Company recorded a net loss in Q1, interest-bearing debt was limited at ¥0.70B against cash and deposits of ¥9.05B, preserving the resilience of its financial base to sustain dividend payments. However, progress against the full-year earnings plan is substantially below target at this point, and the payout ratio will require monitoring depending on the extent of the earnings recovery in the second half.

Risk Factors

1. Upside risk in quality assurance costs: The provision for product warranties increased +114.2% to ¥2.42B from ¥1.13B in the previous year, reaching 17.5% of revenue. This could become a continuing source of pressure on future cash outflows and earnings.

2. Accumulation of inventory and work in process: Work in process was ¥12.62B, accounting for 81.4% of total inventories of ¥15.50B, and increased +4.4% year on year. Delays in production processes or the postponement of acceptance timing may be intensifying the amount of funds tied up in working capital.

3. Deterioration in profitability and cost structure: The SG&A ratio surged to 26.1% from 16.8% in the previous year, with expenses expanding at a pace exceeding the revenue growth rate of +10.1%. As a result, the operating margin deteriorated by approximately 12.0pt to -5.3% from +6.7% in the previous year, making optimization of the cost structure a key challenge.

Industry Benchmark (For Reference; Compiled by the Company)

Industry Benchmark (manufacturing)

Profitability and Returns

The Company is substantially below the industry median on both profitability and return metrics, and its shift into the red ranks in the lower tier of the industry.

Growth and Capital Efficiency

The revenue growth rate exceeds the industry median, indicating that top-line growth is relatively strong within the industry.

※Source: Compiled by the Company

Key Points from the Earnings Results

1. While revenue increased (+10.1%), the gross margin deteriorated from 23.5% in the previous year to 20.8%, and the SG&A ratio deteriorated from 16.8% in the previous year to 26.1%. As these developments occurred concurrently, the operating result shifted from the previous year’s operating profit of ¥0.84B to an operating loss of ¥0.74B.

2. The provision for product warranties surged +114.2% year on year to ¥2.42B, while work in process remained at ¥12.62B, accounting for more than 80% of inventories. The normalization of quality-related costs and inventory is therefore a structural issue that will determine future earnings recovery.

3. Although Q1 revenue progress against the full-year plan was 22.8%, progress in operating income and ordinary income was negative, representing a substantial shortfall. The earnings forecast was revised during the current quarter. Achievement of the plan is predicated on a recovery in profitability during the second half.

Theoretical Stock Price (Reference Value)

This is a mechanically calculated reference range based solely on publicly disclosed data using a residual income model (Ohlson-type model with an explicit 5-year fade period). It is not a forecast of the market price or a recommendation of any specific investment action.

Sensitivity: ¥3,047–¥3,221 at ±1% for the cost of equity, and ¥3,126–¥3,136 at ±0.1 for ω.

Notes:

• As forecast ROE is below the cost of equity, the theoretical value is below book value per share.
• Net assets as of the quarter-end are used (there is a timing difference relative to the full-year forecast).
• As net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.

(Calculation model: Residual income model / Interest rate reference month: 2026-06 / This value does not forecast or guarantee the future stock price)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings report data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, with consultation with a professional as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

FY2027 Q1 was a materially weak earnings quarter: 10.1% revenue growth failed to cover a sharp increase in selling, general and administrative expenses, resulting in an operating loss. Revenue rose to ¥13.783bn from ¥12.517bn in the prior-year quarter. Gross profit declined 2.7% year on year to ¥2.863bn despite the higher sales base. Gross margin compressed by approximately 270 basis points to 20.8% from 23.5%. SG&A increased 71.2% year on year to ¥3.599bn, exceeding gross profit by ¥736m and driving the operating loss. Operating income swung from a ¥838m profit to a ¥736m loss, equivalent to an operating-margin decline of roughly 1,200 basis points to negative 5.3%. Ordinary income was a ¥584m loss, compared with ¥1.073bn profit a year earlier. Net income attributable to owners was a ¥403m loss, versus a ¥772m profit in the prior-year quarter, and EPS was negative ¥26.29. Non-operating dividend income of ¥122m provided some support, but it was insufficient to offset the operating deficit. Annualized ROE was negative 3.2%, driven primarily by the negative net margin rather than leverage. The balance sheet remains conservatively financed, with a 326.6% current ratio, debt-to-equity of 0.30x, and cash equal to 13.58x short-term loans. However, manufacturing working capital remains demanding, with annualized DSO of 61 days, DIO of 130 days, and a 160-day cash conversion cycle. Work in process represents 81.4% of inventory, indicating substantial capital tied up in the production cycle. Product-warranty provisions of ¥2.418bn, equal to 17.5% of quarterly revenue, are a major operating and quality-cost item requiring close scrutiny. Management has revised its earnings forecast, while maintaining the dividend forecast, implying confidence in a substantial recovery after the first-quarter loss. Q1 revenue progress is 22.8% of the full-year forecast, broadly close to the 25% seasonal benchmark, but operating-profit and net-income progress are materially behind because both remain negative. The central issue for the remainder of FY2027 is whether revenue growth can translate into restored gross margin and SG&A absorption while working-capital intensity and warranty obligations are contained.

Profitability Analysis

The annualized three-factor DuPont decomposition produces ROE of negative 3.2%, comprising a negative 2.9% net profit margin, 0.829x asset turnover, and 1.30x financial leverage. The negative net margin was the decisive driver of the negative return on equity, while leverage remains modest and is not the source of the earnings deterioration. Revenue growth of 10.1% did not convert into gross-profit growth: gross profit fell to ¥2.863bn from ¥2.941bn. Accordingly, gross margin fell to 20.8% from approximately 23.5%, a deterioration of about 270bp. The larger adverse movement was in SG&A, which rose to ¥3.599bn from ¥2.102bn, or 71.2% year on year, far outpacing revenue growth. This created negative operating leverage, with the operating margin falling from approximately 6.7% to negative 5.3%. The annualized EBIT margin of negative 5.3% is below the 5% efficiency threshold and is the principal profitability concern. The five-factor DuPont tax burden was 0.690, while the 0.793 interest burden reflects that non-operating items were unfavorable relative to the operating loss on a mathematical basis. Interest expense itself was only ¥2m and is immaterial in relation to the company’s balance-sheet capacity; the negative interest-coverage ratio is a consequence of negative EBIT rather than heavy cash interest costs. Dividend income of ¥122m accounted for 73.9% of non-operating income and partly mitigated the ordinary loss. The recovery in profitability therefore depends principally on normalizing gross-margin performance and reducing or absorbing the elevated SG&A base, rather than on financial restructuring.

Growth Assessment

Sales growth was positive at 10.1% year on year, but its quality was weak because gross profit declined and operating profit turned negative. The divergence suggests that pricing, sales mix, production costs, or warranty-related costs did not support the higher revenue base. Full-year revenue guidance is ¥60.480bn, up 2.3% year on year, and Q1 represents 22.8% progress against that target, only 2.2 percentage points below the standard 25% first-quarter run rate. Full-year operating-income guidance is ¥3.730bn, down 20.8% year on year, implying a 6.2% full-year operating margin. Q1’s ¥736m operating loss equates to negative 19.7% progress versus the full-year operating-income target, 44.7 percentage points below the standard 25% benchmark. Net income attributable to owners is forecast at ¥3.570bn, and Q1’s loss equates to negative 11.3% progress, 36.3 percentage points below the normal first-quarter benchmark. The revised forecast therefore requires a pronounced earnings inflection from Q2 onward. The omitted segment disclosure reflects the predominance of the measuring-instruments-related business, making this business the effective core earnings driver. In manufacturing operations, the high proportion of work in process points to potential production-cycle bottlenecks or extended project completion periods that could restrain margin conversion. Sustained growth should be assessed through gross-margin recovery, SG&A discipline, warranty-provision movements, and reduction in working-capital days.

Financial Health

Liquidity is strong, with current assets of ¥38.218bn against current liabilities of ¥11.701bn, producing a current ratio and quick ratio of 326.6%. Working capital is ¥26.517bn, providing a substantial buffer against short-term obligations. Cash and deposits of ¥9.046bn exceed short-term loans of ¥666m by 13.58x. Interest-bearing debt totals only ¥700m, equivalent to 1.4% of capital and a debt-to-equity ratio of 0.30x. Total liabilities represent 23.4% of total assets, while total equity represents 76.6%, indicating a strong equity-funded capital structure. Although 95.1% of borrowings are short term, refinancing risk is mitigated by the very large cash balance, strong current ratio, and low absolute debt level. The negative interest-coverage ratio of negative 368.0x should be interpreted as an operating-loss warning rather than evidence of debt-service strain, given the ¥2m interest expense and limited debt outstanding. Net defined-benefit liabilities of ¥3.623bn are the principal reported non-debt long-term obligation. Accounts receivable fell 25.6% year on year to ¥9.229bn, which releases balance-sheet capital and may reflect collection progress, lower billed balances, or timing of sales recognition. Electronic receivables of ¥3.405bn should be considered alongside trade receivables in evaluating customer-credit exposure. Investment securities of ¥10.574bn account for 15.9% of assets, making equity-market valuation movements relevant to comprehensive income and equity. Comprehensive income was a ¥560m loss, larger than the ¥403m net loss, owing in part to negative valuation differences on securities and defined-benefit remeasurements. Product-warranty provisions increased to ¥2.418bn from ¥1.129bn, materially increasing the company’s obligation base and requiring monitoring alongside operating profitability.

Notable B/S Changes

Accounts receivable: -¥3.180bn (-25.6%) to ¥9.229bn — supports liquidity and reduces billed receivables, though it should be assessed alongside annualized DSO of 61 days and electronic receivables of ¥3.405bn. Product-warranty provision: +¥1.289bn (+114.2%) to ¥2.418bn — a substantial increase in potential quality-related obligations and a major risk to future margins and operating cash conversion.

Cash Flow Quality

The operational cash-conversion profile is currently the key earnings-quality consideration. Annualized DSO of 61 days exceeds the 60-day warning threshold, indicating slower customer collection than the stated manufacturing benchmark. Annualized inventory days of 130 are well above the 90-day warning threshold, increasing the amount of capital committed to production and inventory. The annualized cash conversion cycle of 160 days is above the 120-day warning level and exposes liquidity to delays in production completion, billing, collection, or inventory turnover. Total reported inventory is ¥15.500bn, comprising ¥12.618bn of work in process, ¥2.543bn of finished goods, and ¥339m of raw materials. Work in process represents 81.4% of inventory, substantially above the 40% warning threshold, and is consistent with a production cycle that absorbs significant working capital. The receivables reduction is positive for balance-sheet liquidity, but its sustainability should be evaluated in conjunction with sales timing and the elevated DSO measure. Accounts payable of ¥3.720bn and electronic payables of ¥1.692bn provide some supplier financing, but do not offset the long production and collection cycle. The ¥2.418bn warranty provision, equal to 17.5% of Q1 revenue, is unusually high and may require future cash settlement, adding to operational cash demands. The combination of high WIP, long inventory days, extended cash conversion, and high warranty obligations raises the sensitivity of cash generation to production execution and product-quality outcomes.

Dividend Sustainability

The full-year dividend forecast is ¥120 per share and has not been revised despite the earnings-forecast revision. Against forecast EPS of ¥232.70, the implied dividend payout ratio is approximately 51.6%, within the stated 60% sustainability benchmark. The Q1 loss of ¥26.29 per share means that interim earnings do not provide coverage on a quarterly run-rate basis, so dividend sustainability depends on delivery of the forecasted second-half earnings recovery. The company’s low debt, substantial liquidity, and equity base of ¥50.979bn provide balance-sheet capacity to maintain the indicated distribution. Retained earnings of ¥38.843bn also provide a substantial accumulated earnings reserve. Nevertheless, preservation of the dividend outlook will depend on converting the forecast revenue base into positive operating income and managing working-capital and warranty-related cash requirements. The analysis refers only to the dividend payout ratio; no total return ratio is calculated.

Risk Assessment

Business risks include Margin recovery risk: gross margin declined about 270bp to 20.8% despite 10.1% sales growth, indicating that higher volume has not translated into favorable pricing or production-cost absorption., Operating-leverage risk: SG&A rose 71.2% year on year, far exceeding revenue growth and causing the operating margin to fall to negative 5.3%., Manufacturing execution risk: annualized inventory days of 130, a 160-day cash conversion cycle, and an 81.4% WIP share point to a lengthy production cycle and potential completion or throughput bottlenecks., Product-quality and warranty risk: the ¥2.418bn warranty provision equals 17.5% of revenue and more than doubled year on year, creating potential cost, customer-relationship, and cash-settlement exposure., Core-business concentration risk: the measuring-instruments-related business dominates the group, so performance is concentrated in one principal business category..

Financial risks include Forecast-delivery risk: Q1 operating income and net income are negative against full-year targets of ¥3.730bn and ¥3.570bn, respectively, requiring a significant recovery after Q1., Working-capital risk: DSO of 61 days is above the warning threshold, while high WIP and inventory days increase the amount of capital tied up before cash collection., Investment-portfolio valuation risk: investment securities amount to ¥10.574bn, or 15.9% of assets, and negative securities valuation movements contributed to the comprehensive loss., Short-term debt concentration: 95.1% of debt is short term, although the ¥666m short-term-loan balance is modest relative to ¥9.046bn of cash., Profit-based debt-service metric risk: negative EBIT produces negative interest coverage, so continuation of operating losses would weaken earnings-based credit metrics even though absolute interest expense is minimal..

Key concerns include Highest priority is whether gross-margin recovery and SG&A normalization can reverse the Q1 operating loss., The scale and drivers of the warranty provision should be monitored closely because it is material relative to quarterly sales and has risen sharply year on year., Production-cycle efficiency is a significant concern given the 130-day annualized DIO, 160-day annualized cash conversion cycle, and WIP concentration., The maintained dividend forecast is dependent on a large earnings recovery over the remaining quarters., The revised earnings forecast increases the importance of quarterly evidence that the anticipated recovery is being realized..

Investment Implications

Key takeaways include Revenue growth remains positive, but Q1 demonstrated severe negative operating leverage as SG&A growth substantially exceeded sales growth., Annualized ROE of negative 3.2% and annualized ROIC of negative 4.8% reflect weak current-period capital efficiency, primarily because of the operating loss., Balance-sheet solvency is strong, with low debt, a 326.6% current ratio, and cash substantially exceeding short-term loans., The major operational issues are gross-margin compression, high warranty provisions, high WIP, and an extended cash conversion cycle., Full-year guidance assumes a substantial post-Q1 turnaround, making earnings momentum over subsequent quarters the principal determinant of financial-performance validation..

Metrics to watch include Gross margin and operating margin relative to Q1 levels of 20.8% and negative 5.3%, SG&A growth relative to revenue growth, Warranty provision balance and warranty expense relative to revenue, Annualized DSO, DIO, WIP share of inventory, and cash conversion cycle, Progress toward full-year revenue guidance of ¥60.480bn and operating-income guidance of ¥3.730bn, Investment-securities valuation movements and their effect on comprehensive income.

Regarding relative positioning, The company combines a strong, low-leverage balance sheet with currently weak operating efficiency. Relative to typical manufacturing benchmarks, liquidity and debt capacity are favorable, but the negative operating margin, negative annualized returns, 130-day inventory cycle, 160-day cash conversion cycle, 81.4% WIP concentration, and 17.5% warranty ratio represent elevated operational risk.